Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 25 Feb 2022, 16:06.
Albert Bourla - 23 Feb 2022 Form 4 Insider Report for PFIZER INC (PFE)
- Reporting relationship
- Chairman & CEO, Director
- Issuer ticker
- PFE
- Reported as of
- 23 Feb 2022
- Net transaction value
- -$1,758,047
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2022, 16:06:54 UTC
- Prior SEC filing
- 17 Feb 2022
- Next SEC filing
- 01 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- Susan E. Grant, by power of atty., for Albert Bourla
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 25 Feb 2022.
Change
- Previous filing in this sequence was filed on 17 Feb 2022.
- Current net transaction value: -$1,758,047.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PFE
transaction
Common Stock
Tax liability
- Transaction value
- $1,758,047
- Shares
- -37,509
- Change %
- -15%
- Price
- $46.87
- Shares after
- 209,841
- Date
- 23 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
PFE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,990
- Date
- 23 Feb 2022
- Ownership
- By Rule 16b-3 Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PFE
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +412,081
- Change %
- Price
- $0.000000
- Shares after
- 412,081
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 412,081
- Exercise price
- $45.96
- Footnotes
- F2
PFE
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +362,427
- Change %
- Price
- $0.000000
- Shares after
- 362,427
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 362,427
- Exercise price
- $45.96
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
Footnote F2
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Footnote F3
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.